RGLS
Creative Planning’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,304
| Closed | -$25K | – | 3688 |
|
|
2025
Q1 | $25K | Buy |
14,304
+188
| +1% | +$329 | ﹤0.01% | 3367 |
|
|
2024
Q4 | $22.3K | Sell |
14,116
-2,350
| -14% | -$3.71K | ﹤0.01% | 3311 |
|
|
2024
Q3 | $25.9K | Buy |
+16,466
| New | +$25.9K | ﹤0.01% | 3138 |
|
|
2022
Q2 | – | Sell |
-12,000
| Closed | -$4K | – | 2380 |
|
|
2022
Q1 | $4K | Sell |
12,000
-2,200
| -15% | -$733 | ﹤0.01% | 2213 |
|
|
2021
Q4 | $4K | Hold |
14,200
| – | – | ﹤0.01% | 2071 |
|
|
2021
Q3 | $10K | Hold |
14,200
| – | – | ﹤0.01% | 2043 |
|
|
2021
Q2 | $12K | Buy |
14,200
+2,200
| +18% | +$1.86K | ﹤0.01% | 1965 |
|
|
2021
Q1 | $19K | Buy |
+12,000
| New | +$19K | ﹤0.01% | 2310 |
|
|
2017
Q4 | – | Sell |
-41,000
| Closed | -$51K | – | 1961 |
|
|
2017
Q3 | $51K | Buy |
41,000
+40,000
| +4,000% | +$49.8K | ﹤0.01% | 1758 |
|
|
2017
Q2 | $1K | Sell |
1,000
-15,000
| -94% | -$15.6K | ﹤0.01% | 4367 |
|
|
2017
Q1 | $26K | Buy |
16,000
+12,000
| +300% | +$19.5K | ﹤0.01% | 2921 |
|
|
2016
Q4 | $9K | Buy |
+4,000
| New | +$9K | ﹤0.01% | 3559 |
|
|
2016
Q2 | – | Sell |
-100
| Closed | -$1K | – | 4313 |
|
|
2016
Q1 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 4052 |
|
|
2015
Q4 | – | Sell |
-2,450
| Closed | -$16K | – | 4388 |
|
|
2015
Q3 | $16K | Buy |
+2,450
| New | +$16K | ﹤0.01% | 2882 |
|